Literature DB >> 17159647

Does lung surfactant promote disaggregation of nanostructured titanium dioxide?

Monika Maier1, Bernd Hannebauer, Henning Holldorff, Peter Albers.   

Abstract

OBJECTIVE: Nanostructured titanium dioxide (TiO2) is highly aggregated and agglomerated when inhaled. There are discussions regarding whether lung surfactant may promote the disaggregation of TiO2 particles. We investigated whether dipalmitoyl phosphatidyl-choline (DPPC), the main component of lung surfactant, can split the bonds between TiO2 aggregates and agglomerates.
METHODS: We calculated the energy required to split aggregates into primary particles and agglomerates into aggregates as well the energy of the interaction of a TiO2 surface with a DPPC bilayer. To test the calculations, we measured the particle size distribution of TiO2 suspensions in a pulmonary liquid model.
RESULTS: Calculated splitting energy between TiO2 aggregates was 1 J/m2 and 10 J/m2 between primary particles. The calculated interaction between DPPC and TiO2 was significantly weaker (0.05 J/m2). Calculations were shown to be in accordance with the measured particle size distribution of TiO2 suspensions in the pulmonary liquid model.
CONCLUSION: We conclude that lung surfactant does not promote the disaggregation of TiO2 agglomerates and aggregates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159647     DOI: 10.1097/01.jom.0000215405.72714.b2

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  6 in total

1.  "Real-world" precision, bias, and between-laboratory variation for surface area measurement of a titanium dioxide nanomaterial in powder form.

Authors:  Vincent A Hackley; Aleksandr B Stefaniak
Journal:  J Nanopart Res       Date:  2013-06       Impact factor: 2.253

2.  Differences in estimates of size distribution of beryllium powder materials using phase contrast microscopy, scanning electron microscopy, and liquid suspension counter techniques.

Authors:  Aleksandr B Stefaniak; Mark D Hoover; Robert M Dickerson; Gregory A Day; Patrick N Breysse; Ronald C Scripsick
Journal:  Part Fibre Toxicol       Date:  2007-02-28       Impact factor: 9.400

3.  Evaluating the Use of TiO2 Nanoparticles for Toxicity Testing in Pulmonary A549 Cells.

Authors:  Jana Bacova; Petr Knotek; Katerina Kopecka; Ludek Hromadko; Jan Capek; Pavlina Nyvltova; Lenka Bruckova; Ladislava Schröterova; Blanka Sestakova; Jiri Palarcik; Martin Motola; Dana Cizkova; Ales Bezrouk; Jiri Handl; Zdenek Fiala; Emil Rudolf; Zuzana Bilkova; Jan M Macak; Tomas Rousar
Journal:  Int J Nanomedicine       Date:  2022-09-13

4.  Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide.

Authors:  Tina M Sager; Vincent Castranova
Journal:  Part Fibre Toxicol       Date:  2009-05-04       Impact factor: 9.400

Review 5.  The safety of nanostructured synthetic amorphous silica (SAS) as a food additive (E 551).

Authors:  Claudia Fruijtier-Pölloth
Journal:  Arch Toxicol       Date:  2016-10-03       Impact factor: 5.153

6.  Effects of Sample Preparation on Particle Size Distributions of Different Types of Silica in Suspensions.

Authors:  Rodrigo R Retamal Marín; Frank Babick; Gottlieb-Georg Lindner; Martin Wiemann; Michael Stintz
Journal:  Nanomaterials (Basel)       Date:  2018-06-21       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.